Avecho Biotechnology Limited [ASX:AVE] share price and news 2022

Company Description

Avecho Biotechnology Limited (AVE , formerly Phosphagenics Limited) develops and commercialises Human and Animal Health products using its proprietary drug delivery system called TPM (Targeted Penetration Matrix).

Avecho Biotechnology Limited belongs to Health Care sector and under industry of Pharmaceuticals. You can get more information about this company via their website: http://www.avecho.com.au.

This a small cap company with market cap of 40 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is greater than both sector and market. On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 12.9 0
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how ave dividend grows in the recent years.